From the 156 participants included in the BEAMS study, 105 were screened for this sub-study between August 2017 and August 2019: 27 were excluded because they were taking or had taken systemic glucocorticoids in the previous four weeks; 2 were taking insulin for diabetes and 53 chose not to participate. Here, INS is linked to diabetes mellitus.